Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adrenocortical Carcinoma × cabazitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 34 Neoplasm Metastasis 10 Recurrence 7 Breast Neoplasms 5 Carcinoma, Transitional Cell 4 Stomach Neoplasms 3 Neoplastic Cells, Circulating 3 Metastatic Castration-resistant Prostate Cancer 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Ovarian Neoplasms 2 Neoplasms 2 Glioblastoma 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Thrombocytosis 1 Prostatic Neoplasms, Castration-Resistant 1 Prostate Cancer, Hereditary, 7 1 Prostate Cancer Metastatic 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Penile Neoplasms 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Nonseminomatous germ cell tumor 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1

Interventions

Mitotane 7 Cisplatin 6 pembrolizumab 4 Etoposide 3 Doxorubicin 3 camrelizumab 2 apatinib 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Cytoreduction Surgical Procedures 2 sodium thiosulfate 1 iodophenyl metomidate 1 fludarabine phosphate 1 dostarlimab 1 cemiplimab 1 cabozantinib 1 cabazitaxel 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Suramin 1 Streptozocin 1 Sorafenib 1 Radiation 1 Paclitaxel 1 Observation 1 Nivolumab 1 Megestrol Acetate 1 Lymph Node Excision 1 Ipilimumab 1 Interleukin-13 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03257891 2018-04-11

CabACC

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Unknown

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡